Phenylalanine
From Wikipedia, the free encyclopedia
Categories: All articles with unsourced statements | Articles with unsourced statements since February 2008 | Proteinogenic amino acids | Glucogenic amino acids | Ketogenic amino acids | Aromatic amino acids | Essential amino acids
Phenylalanine (abbreviated as Phe or F)[1] is an α-amino acid with the formula HO2CCH(NH2)CH2C6H5. This essential amino acid is classified as nonpolar because of the hydrophobic nature of the benzyl side chain. The codons for L-phenylalanine are UUU and UUC. It is a white, powdery solid. L-Phenylalanine (LPA) is an electrically-neutral amino acid, one of the twenty common amino acids used to biochemically form proteins, coded for by DNA.
BiosynthesisPhenylalanine cannot be made by animals, which have to obtain it from their diet. It is produced by plants and most microorganisms from prephenate, an intermediate on the shikimate pathway.[2] Image:Phenylalanine biosynthesis.png Prephenate is decarboxylated with loss of the hydroxyl group to give phenylpyruvate. This species is transaminated using glutamate as the nitrogen source to give phenylalanine and α-ketoglutarate. Other biological rolesL-phenylalanine can also be converted into L-tyrosine, another one of the DNA-encoded amino acids. L-tyrosine in turn is converted into L-DOPA, which is further converted into dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline) (the latter three are known as the catecholamines). Phenylalanine uses the same active transport channel as tryptophan to cross the blood-brain barrier, and, in large quantities, interferes with the production of serotonin. Lignin is derived from phenylalanine and from tyrosine. Phenylalanine is converted to cinnamic acid by the enzyme phenylalanine ammonia lyase.[2] PhenylketonuriaThe genetic disorder phenylketonuria (PKU) is the inability to metabolize phenylalanine. Individuals with this disorder are known as "phenylketonurics" and must abstain from consumption of phenylalanine. This dietary restriction also applies to pregnant women with hyperphenylalanine (high levels of phenylalanine in blood) because they do not properly metabolize the amino acid phenylalanine. Persons suffering from PKU must monitor their intake of protein to control the buildup of phenylalanine as their bodies convert protein into its component amino acids. A non food source of phenylalanine is the artificial sweetener aspartame. This compound, sold under the trade names "Equal" and "NutraSweet", is metabolized by the body into several chemical byproducts including phenylalanine. The breakdown problems phenylketonurics have with protein and the attendant build up of phenylalanine in the body also occurs with the ingestion of aspartame, although to a lesser degree. Accordingly, all products in the U.S. and Canada that contain aspartame must be labeled: "Phenylketonurics: Contains phenylalanine." In the UK, foods containing aspartame must carry ingredients panels that refer to the presence of 'aspartame or E951',[3] and they must be labeled with a warning "Contains a source of phenylalanine". These warnings are specifically placed to aid individuals who suffer from PKU so that they can avoid such foods. Geneticists have recently sequenced the genome of macaques. Their investigations have found "some instances where the normal form of the macaque protein looks like the diseased human protein" including markers for PKU.[4] D- and DL-phenylalanineThe unnatural stereoisomer D-phenylalanine (DPA) is available through conventional organic synthesis either as a single enantiomer or as a component of the racemic mixture. It does not participate in protein biosynthesis although it is found in proteins, in small amounts, particularly aged proteins and food proteins that have been processed. The biological functions of D-amino acids remain unclear. Some D-amino acids, such as D-phenylalanine, may have pharmacological activity. DL-Phenylalanine is marketed as a nutritional supplement for its putative analgesic and antidepressant activities. The putative analgesic activity of DL-phenylalanine may be explained by the possible blockage by D-phenylalanine of enkephalin degradation by the enzyme carboxypeptidase A.[5] The mechanism of DL-phenylalanine's putative antidepressant activity may be accounted for by the precursor role of L-phenylalanine in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects.[citation needed] D-Phenylalanine is absorbed from the small intestine, following ingestion, and transported to the liver via the portal circulation. A fraction of D-phenylalanine appears to be converted to L-phenylalanine. D-Phenylalanine is distributed to the various tissues of the body via the systemic circulation. D-Phenylalanine appears to cross the blood-brain barrier with less efficiency than L-phenylalanine. A fraction of an ingested dose of D-phenylalanine is excreted in the urine. HistoryThe genetic codon for phenylalanine was the first to be discovered. Marshall W. Nirenberg discovered that insertion of m-RNA made up of multiple uracil repeats into E. coli, the bacterium produced a new protein, made up solely of repeated phenylalanine amino acids. References
External links
bg:Фенилаланин ca:Fenilalanina cs:Fenylalanin da:Fenylalanin de:Phenylalanin es:Fenilalanina eo:Fenilalanino fr:Phénylalanine ko:페닐알라닌 hr:Fenilalanin id:Fenilalanin it:Fenilalanina he:פנילאלנין lv:Fenilalanīns lb:Phenylalanin lt:Fenilalaninas hu:Fenilalanin nl:Fenylalanine ja:フェニルアラニン no:Fenylalanin pl:Fenyloalanina pt:Fenilalanina ru:Фенилаланин sr:Фенилаланин fi:Fenyylialaniini sv:Fenylalanin tr:Fenilalanin uk:Фенілаланін | ||||||||||||||||||||||||||||||||||||||
